262 related articles for article (PubMed ID: 29691269)
1. Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.
McBride A; Campen CJ; Camamo J; Maloney M; Persky D; Kurtin SE; Barket NL; Krishnadasan R; Elquza E; Anwer F; Weibel K
Am J Health Syst Pharm; 2018 May; 75(9):e246-e258. PubMed ID: 29691269
[TBL] [Abstract][Full Text] [Related]
2. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
Corsi MP; Shea K; W Knoebel R
J Oncol Pharm Pract; 2020 Sep; 26(6):1324-1330. PubMed ID: 31822200
[TBL] [Abstract][Full Text] [Related]
3. Making moves: Transitioning R-EPOCH to the ambulatory setting.
Martin AL; Frank JP; Waggoner ML
J Oncol Pharm Pract; 2018 Dec; 24(8):617-622. PubMed ID: 28782408
[TBL] [Abstract][Full Text] [Related]
4. Development and implementation of an interdisciplinary oncology program in a community hospital.
Chung C; Collins A; Cui N
Am J Health Syst Pharm; 2011 Sep; 68(18):1740-7. PubMed ID: 21880891
[TBL] [Abstract][Full Text] [Related]
5. Conversion from paper to electronic acute care chemotherapy orders.
Offei-Nkansah G; Amerine LB
Am J Health Syst Pharm; 2020 Sep; 77(18):1516-1521. PubMed ID: 32699883
[TBL] [Abstract][Full Text] [Related]
6. Implementation and evaluation of a team-based pharmacy practice model in a community health system.
Gill TK; Thornton LM; Schroeder TR; Garrelts JC; Schminke BC; Utz KJ; Gerlach CT
Am J Health Syst Pharm; 2019 Mar; 76(7):470-477. PubMed ID: 31415682
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Cost Comparison Evaluation of Inpatient Versus Outpatient Administration of EPOCH-Containing Regimens in Non-Hodgkin Lymphoma.
Evans SS; Gandhi AS; Clemmons AB; DeRemer DL
J Pharm Pract; 2017 Aug; 30(4):400-405. PubMed ID: 27432462
[TBL] [Abstract][Full Text] [Related]
8. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Study of the Effects of Oncology Pharmacist Participation in Treatment on Therapeutic Outcomes and Medical Costs.
Imamura M; Ogawa D; Takatori T; Yamaguchi M; Takata T; Hada T; Ota Y; Uehara T
Biol Pharm Bull; 2017; 40(11):1956-1962. PubMed ID: 29093344
[TBL] [Abstract][Full Text] [Related]
10. Development of an operational productivity tool within a cancer treatment center pharmacy.
Achey TS; Riffle AR; Rose RM; Earl M
Am J Health Syst Pharm; 2018 Nov; 75(21):1736-1741. PubMed ID: 30282665
[TBL] [Abstract][Full Text] [Related]
11. Building an outpatient cancer center pharmacy program across a tristate region.
Skledar SJ; Doedyns A; Yourich B
Am J Health Syst Pharm; 2015 Jan; 72(2):126-32. PubMed ID: 25550136
[TBL] [Abstract][Full Text] [Related]
12. Implementation of transitions-of-care services through acute care and outpatient pharmacy collaboration.
Gilmore V; Efird L; Fu D; LeBlanc Y; Nesbit T; Swarthout M
Am J Health Syst Pharm; 2015 May; 72(9):737-44. PubMed ID: 25873621
[TBL] [Abstract][Full Text] [Related]
13. Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital.
Keshvani N; Hon M; Gupta A; Brown TJ; Roy L; Marley E; Lindsey S; Johnson DH; Sadeghi N; Li HC
J Oncol Pract; 2019 Aug; 15(8):e644-e651. PubMed ID: 31206340
[TBL] [Abstract][Full Text] [Related]
14. Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
Kilcup M; Schultz D; Carlson J; Wilson B
J Am Pharm Assoc (2003); 2013; 53(1):78-84. PubMed ID: 23636160
[TBL] [Abstract][Full Text] [Related]
15. Use of a pharmacy protocol to convert standard rituximab infusions to rapid infusion shortens outpatient infusion clinic visits.
Swan JT; Zaghloul HA; Cox JE; Murillo JR
Pharmacotherapy; 2014 Jul; 34(7):686-94. PubMed ID: 24706572
[TBL] [Abstract][Full Text] [Related]
16. An Evaluation of the Effect of Pharmacist-Led Comprehensive Chemotherapy Consultation Services on Outpatient Appointment Adherence.
Sebring EJ; Rudisill MA; Bates JS; Auten JJ; Urick BY; Clark SM
J Manag Care Spec Pharm; 2020 Jun; 26(6):723-727. PubMed ID: 32463774
[TBL] [Abstract][Full Text] [Related]
17. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
18. Implementing clinical pharmacy services in an outpatient oncology clinic.
Caselnova DA; Dzierba SH; O'Neill MS; Dillon KR; Farley PC
Am J Hosp Pharm; 1985 Jun; 42(6):1348-52. PubMed ID: 4014251
[TBL] [Abstract][Full Text] [Related]
19. Implementation, justification, and expansion of ambulatory clinical pharmacy services.
Lepinski PW; Woller TW; Abramowitz PW
Top Hosp Pharm Manage; 1992 Jan; 11(4):86-92. PubMed ID: 10128691
[TBL] [Abstract][Full Text] [Related]
20. Expansion of clinical pharmacy through increased use of outpatient pharmacists for anticoagulation services.
Philip A; Green M; Hoffman T; Gautreaux S; Wallace D; Roux R; Garey KW
Am J Health Syst Pharm; 2015 Apr; 72(7):568-72. PubMed ID: 25788511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
